Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
HTEC vs FMED
Shared holdings
14
HTEC covered by FMED
19.50%
FMED covered by HTEC
19.50%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
HTEC (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 2.20% | |
| ARROWHEAD PHARMACEUTICALS INC | 2.18% | |
| GUARDANT HEALTH INC | 2.16% | |
| ADAPTIVE BIOTECHNOLOGIES CORP | 2.13% | |
| PENUMBRA INC | 2.12% | |
| AXOGEN INC | 2.02% | |
| ILLUMINA INC | 2.00% | |
| VERTEX PHARMACEUTICALS INC | 2.00% | |
| TWIST BIOSCIENCE CORP | 1.97% | |
| STRYKER CORP | 1.96% | |
| THERMO FISHER SCIENTIFIC INC | 1.95% | |
| EUROFINS SCIENTIFIC SE (BEARER) | 1.95% | |
| LivaNova PLC ORD GBP1.00 (DI) | 1.89% | |
| SIEMENS HEALTHINEERS AG COMMON STOCK | 1.88% | |
| BOSTON SCIENTIFIC CORP | 1.85% | |
| KONINKLIJKE PHIL | 1.85% | |
| REGENERON PHARMACEUTICALS INC | 1.84% | |
| NATERA INC | 1.83% | |
| NOVANTA INC | 1.82% | |
| IQVIA HOLDINGS INC | 1.80% | |
| LONZA GROUP -REG | 1.78% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 1.75% | |
| CHARLES RIVER LABS INTL INC | 1.73% | |
| QIAGEN NV ORD SHARES | 1.72% | |
| MEDPACE HOLDINGS INC | 1.71% | |
| GLAUKOS CORP | 1.70% | |
| INTUITIVE SURGICAL INC | 1.69% | |
| JD HEALTH INTERN | 1.69% | |
| EXACT SCIENCES CORP | 1.68% | |
| NOVOCURE LTD | 1.66% | |
| GLOBUS MEDICAL INC | 1.66% | |
| GRAIL INC | 1.65% | |
| DANAHER CORP | 1.65% | |
| CAREDX INC | 1.63% | |
| INCYTE CORP | 1.62% | |
| TECAN GROUP AG-R | 1.62% | |
| DIASORIN SPA COMMON STOCK | 1.60% | |
| EDWARDS LIFESCIENCES CORP COMMON STOCK | 1.58% | |
| ARTIVION INC | 1.56% | |
| BECTON DICKINSON AND CO COMMON STOCK | 1.50% | |
| BRISTOL-MYERS SQUIBB CO | 1.50% | |
| ABBOTT LABORATORIES COMMON STOCK | 1.45% | |
| TEMPUS AI INC-A | 1.45% | |
| ALNYLAM PHARMACEUTICALS INC | 1.43% | |
| GE HEALTHCARE TECHNOLOGIES INC WI | 1.42% | |
| BIOMARIN PHARMACEUTICAL INC | 1.41% | |
| AGILENT TECHNOLOGIES INC | 1.38% | |
| OMNICELL INC | 1.37% | |
| IRHYTHM TECHNOLOGIES INC | 1.37% | |
| BIO-RAD LABORATORIES-A COMMON STOCK | 1.36% |
FMED (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| Fidelity Securities Lending Cash Central Fund | 11.15% | |
| DANAHER CORP | 3.77% | |
| UCB SA | 3.61% | |
| BOSTON SCIENTIFIC CORP | 3.58% | |
| ARGENX SE SPONSORED ADR | 3.41% | |
| COGENT BIOSCIENCES INC | 3.40% | |
| ALNYLAM PHARMACEUTICALS INC | 2.94% | |
| INTUITIVE SURGICAL INC | 2.79% | |
| VEEVA SYSTEMS-A | 2.65% | |
| INSULET CORP | 2.29% | |
| MODERNA INC | 2.28% | |
| WAYSTAR HOLDING CORP | 2.24% | |
| EDWARDS LIFESCIENCES CORP | 2.20% | |
| LIFESTANCE HEALTH GROUP INC | 2.18% | |
| VAXCYTE INC | 2.03% | |
| INSMED INC | 1.74% | |
| Sartorius Stedim Biotech S.A. | 1.74% | |
| STRYKER CORP | 1.65% | |
| LILLY ELI and CO | 1.58% | |
| PRIVIA HEALTH GROUP INC | 1.56% | |
| THERMO FISHER SCIENTIFIC INC | 1.55% | |
| LEGEND BIOTECH CORP SPON ADR | 1.53% | |
| 10X GENOMICS INC | 1.51% | |
| PENUMBRA INC | 1.51% | |
| KYMERA THERAPEUTICS INC | 1.33% | |
| STOKE THERAPEUTICS INC | 1.33% | |
| Ascendis Pharma A/S | 1.32% | |
| UNITEDHEALTH GRP | 1.27% | |
| NATERA INC | 1.27% | |
| LONZA GROUP -REG | 1.26% | |
| CYTOKINETICS INC | 1.20% | |
| CARIS LIFE SCIENCES INC | 1.17% | |
| CRINETICS PHARMACEUTICALS INC | 1.14% | |
| DEXCOM INC | 1.12% | |
| DISC MEDICINE INC | 1.08% | |
| VERACYTE INC | 1.07% | |
| RESMED INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 0.99% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.89% | |
| NUVALENT INC-A | 0.89% | |
| CYTOMX THERAPEUTICS INC | 0.88% | |
| ALIGNMENT HEALTHCARE INC | 0.84% | |
| ALIGN TECHNOLOGY INC | 0.83% | |
| GUARDANT HEALTH INC | 0.82% | |
| WAVE LIFE SCIENCES LTD | 0.81% | |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 0.78% | |
| ROIVANT SCIENCES LTD | 0.76% | |
| REPLIGEN CORP | 0.74% | |
| ENLIVEN THERAPEUTICS INC | 0.74% | |
| BIO-TECHNE CORP | 0.72% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.